Some EU nations still want Valneva Covid-19 vaccine deal - sources
Skip to main content
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Splash
  • Features
  • Videos
  • Long Read
  • Games
  • Epaper
  • More
    • COVID-19
    • Bangladesh
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Subscribe
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
The Business Standard
FRIDAY, MAY 27, 2022
FRIDAY, MAY 27, 2022
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Splash
  • Features
  • Videos
  • Long Read
  • Games
  • Epaper
  • More
    • COVID-19
    • Bangladesh
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Subscribe
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
Some EU nations still want Valneva Covid-19 vaccine deal - sources

Coronavirus chronicle

Reuters
30 April, 2021, 08:35 pm
Last modified: 30 April, 2021, 08:39 pm

Related News

  • EU to help Bangladesh combat human trafficking: Envoy  
  • EU welcomes Dhaka’s 'openness' to intl election observers at next polls
  • EU brands firm on human rights in supply chain: Expert
  • Ukrainian PM says EU disburses 600m euros to Ukraine
  • How many countries have nuclear weapons and how many are there?

Some EU nations still want Valneva Covid-19 vaccine deal - sources

The EU concluded exploratory talks with Valneva in January for the supply of up to 60 million doses of its vaccine

Reuters
30 April, 2021, 08:35 pm
Last modified: 30 April, 2021, 08:39 pm
Representational Image. Photo: Collected
Representational Image. Photo: Collected

Some EU countries still want Brussels to strike a deal to buy Valneva's Covid-19 vaccine candidate despite a recent setback in talks, as the bloc aim to shore up and diversify supplies, sources familiar with the talks told Reuters.

A spokesman for the European Commission said last week the French vaccine maker had not met conditions required to reach an agreement, two days after the company said it would now give priority to a country by country approach.

The EU concluded exploratory talks with Valneva in January for the supply of up to 60 million doses of its vaccine, which uses inactivated whole virus particles and is derived from the technology behind its licensed Japanese encephalitis shot.

Two sources familiar with the bloc's plans said some EU members, including France and Germany, were still pushing for a deal to help diversify supplies as Europe tries to secure vaccines for the next two years.

"There are around 10 countries interested in a deal with Valneva. The contract is written, but the two sides still need to agree on a few structuring parameters. Once this is cleared, things could rapidly move forward," one of the sources said.

The sources declined to be identified because of the confidential nature of the talks.

Valneva and the European Commission could not immediately be reached for comment.

So far, the EU has bought Covid-19 vaccines from Pfizer/BioNTech, Moderna, AstraZeneca, Johnson & Johnson, CureVac, and Sanofi/GlaxoSmithKline/GSK.

It is currently in negotiations for a third contract with Pfizer and BioNTech, which would mark the world's biggest vaccine supply deal.

The vaccines have different approaches, ranging from the use of recombinant proteins to so-called messenger RNA.

Valneva, which started a late-stage human trial for its shot last week, has signed a deal with Britain for up to 190 million doses by 2025 in a transaction worth potentially up to 1.4 billion euros ($1.7 billion).

The company's vaccine will be produced in Scotland, with an estimated capacity of 200 million doses next year. It will use an adjuvant made by US company Dynavax.

This single location is a concern for the EU, which wants to ensure vaccines are produced on its soil and avoid a scenario where the company could be tempted to prioritise deliveries to Britain to the detriment of the continent, the sources said.

It has embarked on a legal battle against AstraZeneca, which it accuses of holding back doses made in Britain from its supplies to the region.

Germany wants Valneva to agree first that it would not prioritise Britain in deliveries, one of the sources said.

In February, Valneva's chief financial officer David Lawrence told Reuters the group was open to production partnerships in other regions, should its vaccine candidate secure approval and generate enough interest beyond Britain and the EU.

World+Biz

EU / countries / Valneva Covid-19 vaccine

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Plucking the poultry: New tax regime for the sector on cards
    Plucking the poultry: New tax regime for the sector on cards
  • Dr Zahid Hussain. Illustration: TBS
    The economics of remittance subsidy
  • The government needs to continue subsidising both agriculture and non-agriculture sectors to keep inflation under control Photo: Mumit M/TBS
    Commodity rally continues

MOST VIEWED

  • People in protective suits cross a street during lockdown, amid the coronavirus disease (COVID-19) pandemic, in Shanghai, China, May 26, 2022. REUTERS/Aly Song
    Shanghai heading out of lockdown but China still lost in economic gloom
  • A woman wearing a face mask crosses a road at the Central Business District (CBD), amid the coronavirus disease (Covid-19) outbreak in Beijing, China May 10, 2022. REUTERS/Carlos Garcia Rawlins
    Tightening Covid net, Beijing deals out punishments, stark warnings
  • A medical worker takes a swab sample from a person for a nucleic acid test at a makeshift testing site, amid the coronavirus disease (Covid-19) outbreak, in Beijing, China May 23, 2022. REUTERS/Tingshu Wang
    Beijing ramps up Covid quarantine, Shanghai residents decry uneven rules
  • A vial labelled with the Pfizer-BioNTech coronavirus disease (Covid-19) vaccine is seen in this illustration picture taken March 19, 2021. Photo :Reuters
    Pfizer says 3 Covid shots protect children under 5
  • A medical worker takes a swab sample from a person for a nucleic acid test at a makeshift testing site, amid the coronavirus disease (Covid-19) outbreak, in Beijing, China May 23, 2022. REUTERS/Tingshu Wang
    Beijing urges millions to keep working from home amid Covid outbreak menace
  • Picture: PTI
    Saudi Arabia bans travel to India, 15 other countries over Covid outbreaks

Related News

  • EU to help Bangladesh combat human trafficking: Envoy  
  • EU welcomes Dhaka’s 'openness' to intl election observers at next polls
  • EU brands firm on human rights in supply chain: Expert
  • Ukrainian PM says EU disburses 600m euros to Ukraine
  • How many countries have nuclear weapons and how many are there?

Features

The taboo of dining out alone

The taboo of dining out alone

11h | Food
The perfect time for newborn photography is between the first five and 14 days when a baby’s bones are the most malleable for posing. Photo: Courtesy

Is there a market for newborn photography in the country? Studio Picturerific says yes

11h | Panorama
Pakistan finds itself in political turmoil again as Imran Khan pushes for immediate general elections. Photo: Reuters

Supreme Court of Pakistan: Now a candle in the dark

12h | Analysis
Indulge in Momium’s guilt-free dips and spreads

Indulge in Momium’s guilt-free dips and spreads

12h | Food

More Videos from TBS

Fear of food crisis sets across the globe

Fear of food crisis sets across the globe

6h | Videos
Is Mushfiq refraining from self-destructive shots?

Is Mushfiq refraining from self-destructive shots?

7h | Videos
Kanak is ahead of everyone in Guinness Book

Kanak is ahead of everyone in Guinness Book

12h | Videos
What should your CV cover letter look like?

What should your CV cover letter look like?

13h | Videos

Most Read

1
Bangladesh at risk of losing ownership of Banglar Samriddhi
Bangladesh

Bangladesh at risk of losing ownership of Banglar Samriddhi

2
Corporates go cashless…tax cut on cards
NBR

Corporates go cashless…tax cut on cards

3
Photo: Courtesy
Panorama

Misfit Technologies: A Singaporean startup rooted firmly in Bangladesh

4
Tk100 for bike, Tk2,400 for bus to cross Padma Bridge
Bangladesh

Tk100 for bike, Tk2,400 for bus to cross Padma Bridge

5
British International Investment (BII) CEO Nick O’Donohoe. Illustration: TBS
Economy

BII to invest $450m in Bangladesh in 5 years

6
Representational image. Picture: Pixabay
Economy

Govt raises regulatory duty to discourage imports of 130 products

The Business Standard
Top
  • Home
  • Entertainment
  • Sports
  • About Us
  • Bangladesh
  • International
  • Privacy Policy
  • Comment Policy
  • Contact Us
  • Economy
  • Sitemap
  • RSS

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net

Copyright © 2022 THE BUSINESS STANDARD All rights reserved. Technical Partner: RSI Lab